Targeted therapeutic options and future perspectives for HER2-positive breast cancer
Crossref DOI link: https://doi.org/10.1038/s41392-019-0069-2
Published Online: 2019-09-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Jiani
Xu, Binghe
Text and Data Mining valid from 2019-09-13
Version of Record valid from 2019-09-13
Article History
Received: 16 June 2019
Revised: 22 August 2019
Accepted: 22 August 2019
First Online: 13 September 2019
Competing interests
: The authors declare no competing interests.